- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03723083
Expanded Access for CC-2001
December 18, 2018 updated by: Celgene
This is an expanded access program (EAP) for eligible participants designed to provide access to CC-2001.
Study Overview
Study Type
Expanded Access
Expanded Access Type
- Individual Patients
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Summit, New Jersey, United States, 07901
- Celgene
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
-
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
October 25, 2018
First Submitted That Met QC Criteria
October 25, 2018
First Posted (Actual)
October 29, 2018
Study Record Updates
Last Update Posted (Actual)
December 20, 2018
Last Update Submitted That Met QC Criteria
December 18, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CC-2001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Other
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)CompletedOther Injury of Other Intra-abdominal Organs, Initial EncounterUnited States
-
Riverside Pharmacueticals CorporationCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Mayo Clinic; Northwell Health; Duke University; National... and other collaboratorsActive, not recruitingOther CancerUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedOther CancerUnited States
-
Gynuity Health ProjectsCompletedOther AbortionUkraine
-
Life UniversityUniversity of GeorgiaCompletedCognition - OtherUnited States
-
Rambam Health Care CampusUnknown
-
Dana-Farber Cancer InstituteCompletedOther CancerUnited States
-
Dana-Farber Cancer InstituteHarvard Medical School (HMS and HSDM); American Cancer Society, Inc.Completed
Clinical Trials on CC-2001
-
Intellia TherapeuticsRegeneron PharmaceuticalsRecruitingTransthyretin Amyloidosis (ATTR) With CardiomyopathyUnited States, Australia, United Kingdom, New Zealand, Canada
-
Oryzon Genomics S.A.Alzheimer's Drug Discovery FoundationCompletedMild to Moderate Alzheimer's DiseaseUnited States
-
Oryzon Genomics S.A.CompletedBorderline Personality DisorderSpain, Serbia, United States, Germany, Bulgaria
-
Intellia TherapeuticsActive, not recruitingTransthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy | Wild-Type Transthyretin Cardiac AmyloidosisFrance, United Kingdom, New Zealand, Sweden
-
Ichnos Sciences SANot yet recruitingRelapsed/Refractory Multiple MyelomaAustralia
-
Guangdong Hengrui Pharmaceutical Co., LtdRecruiting
-
BenevolentAI BioCompletedParkinson Disease | Excessive Daytime SleepinessUnited States
-
Centro de Estudios en Infectogía PediatricaWithdrawn
-
Alaunos TherapeuticsCompleted
-
Alaunos TherapeuticsCompletedGlioblastoma Multiforme | Anaplastic OligoastrocytomaUnited States